Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726489 · ClinicalTrials.gov registry record · NA
Light Treatment Effectiveness (LITE) Study
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 783
- Enrollment target
NCT03726489: Completed NA study, sponsored by University of Pennsylvania.
NCT03726489 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 783 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03726489, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 783 participants
- Enrollment target
Study Summary
To compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis
Interventions
- DEVICE Daavlin 7 series 3 panel narrow band phototherapy home units
- DEVICE narrow band phototherapy clinic units
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 783 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03726489
The ClinicalTrials.gov registry entry for NCT03726489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 783 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Daavlin 7 series 3 panel narrow band phototherapy home units is the first listed.
NCT03726489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03726489 about?
NCT03726489 is a clinical study titled "Light Treatment Effectiveness (LITE) Study". To compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis
What is the current status of trial NCT03726489?
This trial is currently completed. It is a NA study. The enrollment target is 783 participants. The study started on 2019-03-01. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT03726489?
The interventions under investigation include: Daavlin 7 series 3 panel narrow band phototherapy home units (DEVICE), narrow band phototherapy clinic units (DEVICE).
Who is sponsoring clinical trial NCT03726489?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.